If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
US FDA approval based on NEURO-TTRansform Phase III results
World HRD Congress is a well-known international body of Management Studies
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use
Subscribe To Our Newsletter & Stay Updated
